← Leaderboards
Reena V Kartha
University Of Minnesota
$426,250
Attributed
$426,250
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $232.5K · FY2021–22$250K$187.5K$125K$62.5K$0
'21
'22
Funding mix
By agency
NIH$426,250 · 1
By mechanism
R21$426,250 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Douglas G Mashek$9,730,173
- Alvaro Alonso$12,399,860
- Amer Alam$2,122,232
- Charles P Najt$688,282
- Dinesh Kumar Deelchand$1,309,601
Others in their field
Other Emerging Leaders on “Acids”
- Leonard Freedman · Leidos Biomedical Research, Inc.$54,259,745
- Bala Raja · Luminostics, Inc.$28,624,460
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,132,807
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Dave Beebe · Flambeau Diagnostics Llc$16,670,000
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$14,236,023
Research focus
AcidsAdrenal CortexAdrenal GlandsAdrenoleukodystrophyAdultAdverse EffectsAllogenicBaseBiochemicalBirthBloodBoysBrainBrain PathologyCarrier ProteinsCellsCeramidesCerebrumCharacteristicsClinical ApplicationClinically RelevantClinical Trial ReadinessClinical TrialsAcetylcysteine
Grant awards (2)
Dose Optimization of Nervonic Acid - a Potential Therapy to Alleviate Disease Progression in Adrenoleukodystrophy$193,750
R21 · FY2022 · TR · contact PI
Dose Optimization of Nervonic Acid - a Potential Therapy to Alleviate Disease Progression in Adrenoleukodystrophy$232,500
R21 · FY2021 · TR · contact PI